Trial · NCT01137006
Results by group29
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 29
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maximum Tolerated Dose (MTD) of IMC-20D7S | IMC-20D7S | 20 | mg/kg q2w | ||
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 1A (5 mg/kg, q2w) | SAEs | 1 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 2A (10 mg/kg, q2w) | SAEs | 1 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 3A (20 mg/kg, q2w) | SAEs | 5 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 4A (30 mg/kg, q2w) | SAEs | 2 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 1B (10 mg/kg, q3w) | SAEs | 0 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 2B (20 mg/kg, q3w) | SAEs | 4 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 3B (30 mg/kg, q3w) | SAEs | 0 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 1A (5 mg/kg, q2w) | Other Non-Serious AEs | 3 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 2A (10 mg/kg, q2w) | Other Non-Serious AEs | 3 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 3A (20 mg/kg, q2w) | Other Non-Serious AEs | 8 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 4A (30 mg/kg, q2w) | Other Non-Serious AEs | 3 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 1B (10 mg/kg, q3w) | Other Non-Serious AEs | 2 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 2B (20 mg/kg, q3w) | Other Non-Serious AEs | 4 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 3B (30 mg/kg, q3w) | Other Non-Serious AEs | 3 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 1A (5 mg/kg, q2w) | Deaths | 0 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 2A (10 mg/kg, q2w) | Deaths | 0 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 3A (20 mg/kg, q2w) | Deaths | 0 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 4A (30 mg/kg, q2w) | Deaths | 0 | participants | |
| Number of Participants With Serious Adverse Events (SAEs), Other Non-Serious Adverse Events (AEs), or Death | Cohort 1B (10 mg/kg, q3w) | Deaths | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01137006/results